Impact of Methoxy Polyethylene Glycol-Epoetin Beta on serum magnesium in patients with end stage renal disease undergoing hemo dialysis
Diyala Journal of Medicine · 2018
DOI: 10.26505/djm.14013330403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diyala Journal of Medicine, 2018. Verfasst von Mohanad Mohsen Hassan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Methoxy polyethylene glycol-Epoetin beta (M.PG.E-β) is a long-acting erythropoietin receptor activator treatment indicated for the treatment of patients with anemia associated with end stage renal disease (E.S.R.D). It is the first approved chemically modified erythropoiesis-stimulating agent (E.S.A). Hypermagnesemia is one of the common complications accompanied with E.S.R.D patients submitted to hemodialysis. It progresses early in the course of the disease and increases its rate with the declination in renal efficacy.
Objective
This study targeted to determine the influence of M.PG.E-β therapy on serum Mg+2 levels in patients with E.S.R.D. Patients and Methods: In this study , seventy patients with E.S.R.D on hemodialysis receiving M.PG.E-β and twenty healthy subjects without medical illnesses were included in this case-control cross sectional study.
Results
Patients had significantly higher serum Mg+2 level at the baseline (p
Zitieren
APA
Hassan, M. M., Alwan, A. G., & Alsaedi, A. J. H. (2018). Impact of Methoxy Polyethylene Glycol-Epoetin Beta on serum magnesium in patients with end stage renal disease undergoing hemo dialysis. Diyala Journal of Medicine. https://doi.org/10.26505/djm.14013330403
Vancouver
Hassan MM, Alwan AG, Alsaedi AJH. Impact of Methoxy Polyethylene Glycol-Epoetin Beta on serum magnesium in patients with end stage renal disease undergoing hemo dialysis. Diyala Journal of Medicine. 2018. doi:10.26505/djm.14013330403
BibTeX
@article{Hassan2018,
author = {Hassan, Mohanad Mohsen and Alwan, Adnan Gadbhan and Alsaedi, Ali Jasim Hashim},
title = {Impact of Methoxy Polyethylene Glycol-Epoetin Beta on serum magnesium in patients with end stage renal disease undergoing hemo dialysis},
journal = {Diyala Journal of Medicine},
year = {2018},
doi = {10.26505/djm.14013330403}
}
EUVIMED